3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Vomiting
4
Pain
4
Neoplasms
4
Nausea
3
Pancreatic Neoplasms
2
Cancer Pain
2
Breast Neoplasms
2
Taste Disorders
1
Parasomnias
1
Olfaction Disorders
1
Marijuana Abuse
1
Malnutrition
1
Lung Neoplasms
1
Head and Neck Neoplasms
1
Colonic Neoplasms
1
Carcinoma, Hepatocellular
1
Brain Neoplasms
1
Anxiety Disorders
1
Anorexia
1
Interventions
Melatonin
4
Surveys and Questionnaires
3
Yoga
2
Exercise
2
Control Groups
2
nabiximols
1
Walking
1
Ultraviolet Therapy
1
Tai Ji
1
Sugars
1
Respiration
1
Relaxation Therapy
1
Qigong
1
Modafinil
1
Minocycline
1
Mindfulness
1
Midazolam
1
Massage
1
Intensive Care Units
1
Exercise Movement Techniques
1
Dronabinol
1
Cannabidiol
1
Breathing Exercises
1
Autogenic Training
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Parasomnias
×
Dronabinol
×
Clear all
NCT03948074
2025-09-10
CAFCARS
British Columbia Cancer Agency
Phase 2
Completed
91 enrolled